Chege, G.K.; Chapman, R.E.; Keyser, A.T.; Adams, C.H.; Benn, K.; van Diepen, M.T.; Douglass, N.; Lambson, B.; Hermanus, T.; Moore, P.L.;
et al. Heterologous Immunization with Improved HIV-1 Subtype C Vaccines Elicit Autologous Tier 2 Neutralizing Antibodies with Rapid Viral Replication Control After SHIV Challenge. Viruses 2025, 17, 277.
https://doi.org/10.3390/v17020277
AMA Style
Chege GK, Chapman RE, Keyser AT, Adams CH, Benn K, van Diepen MT, Douglass N, Lambson B, Hermanus T, Moore PL,
et al. Heterologous Immunization with Improved HIV-1 Subtype C Vaccines Elicit Autologous Tier 2 Neutralizing Antibodies with Rapid Viral Replication Control After SHIV Challenge. Viruses. 2025; 17(2):277.
https://doi.org/10.3390/v17020277
Chicago/Turabian Style
Chege, Gerald K., Rosamund E. Chapman, Alana T. Keyser, Craig H. Adams, Kealan Benn, Michiel T. van Diepen, Nicola Douglass, Bronwen Lambson, Tandile Hermanus, Penny L. Moore,
and et al. 2025. "Heterologous Immunization with Improved HIV-1 Subtype C Vaccines Elicit Autologous Tier 2 Neutralizing Antibodies with Rapid Viral Replication Control After SHIV Challenge" Viruses 17, no. 2: 277.
https://doi.org/10.3390/v17020277
APA Style
Chege, G. K., Chapman, R. E., Keyser, A. T., Adams, C. H., Benn, K., van Diepen, M. T., Douglass, N., Lambson, B., Hermanus, T., Moore, P. L., & Williamson, A.-L.
(2025). Heterologous Immunization with Improved HIV-1 Subtype C Vaccines Elicit Autologous Tier 2 Neutralizing Antibodies with Rapid Viral Replication Control After SHIV Challenge. Viruses, 17(2), 277.
https://doi.org/10.3390/v17020277
